Literature DB >> 8740891

Community-based ivermectin distributors: onchocerciasis control at the village level in Plateau State, Nigeria.

F Richards1, C Gonzales-Peralta, E Jallah, E Miri.   

Abstract

The use of community residents as agents for distributing mass ivermectin therapy for onchocerciasis provides a component of community participation absent from mobile team delivery methods. Community-based distribution, however, presupposes preexisting human resources in the endemic villages capable of fulfilling the essential functions of an ivermectin distribution process: mobilizing and educating the population, dispensing the drug, maintaining records, and monitoring and treating adverse reactions. Even when such human resources exist, the community workers must continue to receive tangible support from both external (government and donor agencies) and internal (community) sources. Donor and government agencies must accept that their data collection demands will be limited by the literacy standards of the communities being served. Community leaders must agree to set and use their own local standards of payment (including food stuffs or exchange in kind) to compensate the distributors for their time and efforts. The use of locally available human and remunerative resources is a prerequisite for true community ownership of a program.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8740891     DOI: 10.1016/0001-706x(95)00116-v

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  7 in total

1.  Social sciences research in neglected tropical diseases 1: the ongoing neglect in the neglected tropical diseases.

Authors:  Pascale Allotey; Daniel D Reidpath; Subhash Pokhrel
Journal:  Health Res Policy Syst       Date:  2010-10-21

Review 2.  The architecture and effect of participation: a systematic review of community participation for communicable disease control and elimination. Implications for malaria elimination.

Authors:  Jo-An Atkinson; Andrew Vallely; Lisa Fitzgerald; Maxine Whittaker; Marcel Tanner
Journal:  Malar J       Date:  2011-08-04       Impact factor: 2.979

3.  Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria.

Authors:  Frank O Richards; Abel Eigege; Emmanuel S Miri; Alphonsus Kal; John Umaru; Davou Pam; Lindsay J Rakers; Yohanna Sambo; Jacob Danboyi; Bako Ibrahim; Solomon E Adelamo; Gladys Ogah; Danjuma Goshit; O Kehinde Oyenekan; Els Mathieu; P Craig Withers; Yisa A Saka; Jonathan Jiya; Donald R Hopkins
Journal:  PLoS Negl Trop Dis       Date:  2011-10-11

4.  Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.

Authors:  Darin S Evans; Kal Alphonsus; Jon Umaru; Abel Eigege; Emmanuel Miri; Hayward Mafuyai; Carlos Gonzales-Peralta; William Adamani; Elias Pede; Christopher Umbugadu; Yisa Saka; Bridget Okoeguale; Frank O Richards
Journal:  PLoS Negl Trop Dis       Date:  2014-09-18

5.  An exploratory study of community factors relevant for participatory malaria control on Rusinga Island, western Kenya.

Authors:  Pamela Opiyo; W Richard Mukabana; Ibrahim Kiche; Evan Mathenge; Gerry F Killeen; Ulrike Fillinger
Journal:  Malar J       Date:  2007-04-24       Impact factor: 2.979

6.  From river blindness control to elimination: bridge over troubled water.

Authors:  Robert Colebunders; Maria-Gloria Basáñez; Katja Siling; Rory J Post; Anke Rotsaert; Bruno Mmbando; Patrick Suykerbuyk; Adrian Hopkins
Journal:  Infect Dis Poverty       Date:  2018-03-28       Impact factor: 4.520

7.  The Interruption of Transmission of Human Onchocerciasis by an Annual Mass Drug Administration Program in Plateau and Nasarawa States, Nigeria.

Authors:  Frank O Richards; Abel Eigege; John Umaru; Barminas Kahansim; Solomon Adelamo; Jonathan Kadimbo; Jacob Danboyi; Hayward Mafuyai; Yisa Saka; Gregory S Noland; Chukwuma Anyaike; Michael Igbe; Lindsay Rakers; Emily Griswold; Thomas R Unnasch; B E B Nwoke; Emmanuel Miri
Journal:  Am J Trop Med Hyg       Date:  2020-03       Impact factor: 3.707

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.